CVS HEALTH Corp (CVS) stock analysis
Healthcare · Healthcare Plans
Revenue and net income by fiscal year
| Fiscal year | Revenue | Net income |
|---|---|---|
| 2022 | 322.5B | 4.3B |
| 2023 | 357.8B | 8.3B |
| 2024 | 372.8B | 4.6B |
| 2025 | 402.1B | 1.8B |
Price context
Over the last year CVS HEALTH Corp traded between 68.55 and 109.14, most recently 80.84.
How the verdict is built
Four independent models run on every company: a discounted cash flow, a revenue-driven growth DCF for businesses reinvesting everything into growth, valuation multiples against sector peers, and Graham with a dividend-discount model. They are weighted by the kind of business rather than averaged flat, so a cash-burning grower and a utility are not treated alike.
Strike Optics is an analytics and research tool for education. Nothing here is investment advice.
Other companies
All companies · Valuation glossary · Open the free tier, no account needed.